Comer seeks Dershowitz testimony in Epstein House inquiry

House Oversight Committee Chair James Comer said Wednesday that he will ask Alan Dershowitz, Jeffrey Epstein’s former attorney, to appear before the panel as part of its investigation into Epstein, marking the committee’s next public step after testimony a day earlier from Epstein’s longtime assistant, Lesley Groff.

The immediate effect is plain: the committee is widening the circle of witnesses beyond Epstein’s former staff and toward people who had legal or personal proximity to him. Comer said the decision followed Groff’s testimony on Tuesday and a meeting afterward with several Epstein survivors, according to officials familiar with the panel’s work.

Background

Comer, a Kentucky Republican who chairs the House Committee on Oversight and Government Reform, announced the planned request Wednesday morning. His description of the sequence mattered. He said Groff’s testimony helped shape the decision, and so did his post-hearing meeting with survivors. That places the committee’s next move within the factual record it is building, not as a stand-alone political flourish.

What the committee has actually said is limited but clear. “I am going to ask Alan Dershowitz to come in, we will have questions for him and we will give him an opportunity to come in,” Comer said. He did not, based on the available signal, identify a subpoena, a hearing date, or the specific subject areas members intend to cover. And he did not cite a bill number or vote tally because this is an investigative step by a House committee, not legislation moving through markup or floor procedure.

The panel itself is one of Congress’s broadest investigative bodies. The House Committee on Oversight and Government Reform — now commonly referred to as the Oversight Committee — can request voluntary testimony, conduct transcribed interviews and, if it chooses, escalate to compulsory process. Jeffrey Epstein, the financier whose criminal cases drew scrutiny across federal and state systems, remains the center of that inquiry. Public records on Epstein’s federal prosecution and death have been reviewed repeatedly over the years, including by the Justice Department and in court proceedings covered by the Associated Press and Reuters.

Groff’s role explains why her testimony carries weight. As Epstein’s longtime assistant, she sat near the practical mechanics of his operations — scheduling, communications, access and movement. A committee trying to map who knew what, and when, would naturally start there. That changed when Comer said the panel’s next target would be Dershowitz, whose connection to Epstein came through legal representation and whose name has surfaced for years in public disputes tied to the broader scandal. (The committee has not responded to requests for comment.)

What this means

The committee is now testing whether it can move from documentary reconstruction to accountability through testimony from high-profile figures. That matters because congressional investigations often fail at precisely this point. Staff can gather records. Chairs can preview intentions. But when lawmakers seek answers from people with legal exposure, reputational risk or both, voluntary cooperation becomes harder. If Dershowitz declines, Comer will have to decide whether the inquiry is serious enough to consume the time and institutional capital required for a subpoena fight.

Still, the committee has given itself a procedural opening. Comer framed the request as an opportunity for Dershowitz to appear and answer questions. That is the least coercive route, and often the smartest first one. It allows the witness to cooperate without the spectacle of compulsion, while preserving the committee’s ability to say later that it tried the informal path first. In that respect, the move resembles how House investigators have approached other politically charged inquiries: establish a witness chain, build a record, and only then decide whether confrontation is worth the cost. BreakWire has seen that pattern in other congressional oversight fights, including disputes over executive branch compliance and document production in immigration oversight and foreign-policy scrutiny around Iran diplomacy claims.

The result: survivors now appear to be shaping the committee’s direction in a visible way. Comer said as much when he tied his decision not only to Groff’s testimony but also to his meeting with several Epstein survivors. That is not a minor detail. In congressional investigations, the difference between an inquiry that merely revisits known facts and one that changes the public record often turns on who gets heard, when they are heard, and whether their accounts alter the witness list.

There is also a legal reality here that can get lost in the headline. A request to testify is not a finding of liability, civil or criminal. It is an investigative demand for information. But it does signal that the committee believes the witness may have relevant knowledge. And if the panel proceeds in public, every answer or refusal will become part of a record that can influence other institutions, from litigants to law enforcement to future congressional investigators. For a committee built to air matters in public, that is often the real force of the exercise.

The committee is widening the witness list from Epstein’s staff to figures who stood much closer to his legal defense.

Congressional inquiries often gather momentum through sequencing. One witness leads to another. One transcript surfaces a gap. One private meeting redirects the list. That is what appears to be happening here. And because the panel has not yet indicated whether it will seek closed-door testimony, a public hearing, or compulsory process, the next phase will turn less on rhetoric than on compliance.

The broader context is that Oversight is an institution that can shape public understanding even when it does not produce legislation. It can assemble testimony, publish records, and force choices from reluctant witnesses. But its credibility depends on procedural discipline. If Comer follows Groff’s testimony with a formal invitation, states the topics clearly, and sets a date certain, the inquiry will look methodical. If not, this risks becoming another headline without a durable record. In a Congress where attention scatters fast — as recent debates over public health and schools have shown in measles response and student achievement — process is the difference between a moment and an investigation.

What to watch next is specific: whether the committee sends Dershowitz a formal request, whether it names a date for testimony, and whether Comer signals any move toward subpoena authority if a voluntary appearance does not materialize. Those decisions, likely in the days after Wednesday’s announcement, will show whether the panel is simply extending its witness list or preparing for a more adversarial phase.